Latest in Tag: Novartis Highlight
Latest in Tag: Novartis
Novartis Egypt supports COP27, showcases commitment to water, energy saving
With the participation of the Ministry of Environment represented by Ahmed Hafez, Head of the Central Administration for Inspection and Environmental Compliance, and Ahlam Farouk Ammar, Head of the Central Administration for the Protection and Improvement of Industrial Environment and Energy, Novartisâs Water Panel discussion shed light on its efforts championing climate action and showcasing on-ground progress.
Novartis partners with Baheya, reiterates commitment to breast cancer patients in Egypt
Novartis solidifies support for breast cancer patients with the Waraha Kessa campaign, empowering patients to share their stories
Novartis Egypt and HAYAH Patient Advocacy Group Celebrate World CML Day
Renowned hematologist, Dr Mervat Mattar, Professor of Hematology at Cairo University said, âWorld CML Day is a day to celebrate the progress achieved in managing this disease. We are always keen to participate in dedicated awareness and educational events to support CML patients as best as we can.
Novartis, Sandoz demonstrate pivotal impact of public-private partnerships to strengthen healthcare sustainability
Egyptian healthcare system achieves revolutionary progress, we are privileged to support this ongoing transformation through pivotal partnership initiatives, says Jamal Habash
Novartis launches novel treatment for adult patients with SPMS in Egypt
The event took place in cooperation with the MS Chapter of the Egyptian Society of Neurology Psychiatry and Neurosurgery (E.S.N.P.N) and the Egyptian Society of MS to raise the communityâs awareness of this novel treatment that has shown effectiveness in delaying disease deterioration for SPMS patients.
Novartis reveals new hope with overall survival benefit for HR+/HER2- advanced breast cancer patients
âBreast cancer is the most common form of cancer among Egyptian women affecting up to 34%. Approximately 15 – 20% of these breast cancers are diagnosed at the metastatic stage. Metastatic breast (stage IV) cancer is a breast cancer that has spread beyond the breast to other parts of the body, such as the lungs, liver, bones, or brain,â said Dr. Alaa Kandil, Professor of Clinical Oncology, Faculty of Medicine, Alexandria University.
Breakthrough treatment from Novartis sparks new hope for HR+/HER2- advanced breast cancer patients
âBreast cancer is the most common form of cancer among Egyptian women, affecting up to 34% of women in the country. Approximately 20% of these breast cancer cases progress to the metastatic stage8. Metastatic breast cancer, or Phase IV breast cancer, is breast cancer that has spread beyond the breast to other parts of the body (such as the lungs, liver, bones or brain)9â said Prof. Hamdy Abdelazim of Clinical Oncology, Faculty of Medicine, Cairo University.
Novartis Egypt launches campaign to address critical risk of high blood cholesterol
46% of deaths in country caused by cardiovascular disease
Novartis remains committed to supporting Egyptâs COVID-19 fight
Pharmaceutical company announces formation of $40m global Novartis COVID-19 Response Fund
Novartis launches âOncology On Airâ campaign for raising awareness on breast cancer
Breast cancer responsible for about 15% of deaths of tumours
Sales of pharmaceutical companies increase by EGP 10bn, growing by 31%
Factoriesâ revenues amounted to EGP 5bn in November, despite calls for raising prices
Generic drug competition hits Novartis sales
The Swiss pharmaceutical giant Novartis has said its net profit slipped 3 percent in the second quarter. It cited tough competition for its top cancer drug by new generic medications in the United States.
